An epigenetic vaccine model active in the prevention and treatment of melanoma
about
Exploiting tumor epigenetics to improve oncolytic virotherapyHistone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune TherapyThe Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor EfficacySystems biology approach to identification of biomarkers for metastatic progression in cancer.A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumors.Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategiesMHC class II regulation by epigenetic agents and microRNAs.Regulation of immune responses by histone deacetylase inhibitorsImpact of brief exercise on peripheral blood NK cell gene and microRNA expression in young adults.Restoration of immune response gene induction in trophoblast tumor cells associated with cellular senescenceEpigenetics and dermatological disease.The modulation of Dicer regulates tumor immunogenicity in melanoma.Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect.Histone deacetylase inhibitors in the generation of the anti-tumour immune response.Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer.Epigenetics of melanoma: implications for immune-based therapies.Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer.EBP1 and DRBP76/NF90 binding proteins are included in the major histocompatibility complex class II RNA operon.The role of oncolytic virus immunotherapies to subvert cancer immune evasion.The anticancer effects of HDAC inhibitors require the immune system.Metal-dependent Deacetylases: Cancer and Epigenetic RegulatorsThe epigenetic regulation of Dicer and microRNA biogenesis by Panobinostat.Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiersModulation of antitumor immunity with histone deacetylase inhibitors.Epigenetically regulated tumor-associated antigens in melanomaCombined HDAC and BET Inhibition Enhances Melanoma Vaccine Immunogenicity and Efficacy
P2860
Q21131237-709C3D90-3554-412A-AD60-AEC0763BF3DCQ26783032-F233F831-927E-4BFF-9F0C-D2B77002D144Q28076473-200A3D65-FE44-4BC3-AA58-AE92AC148B0DQ33369631-594662DB-CE7A-43B1-B64C-C9F9EBBA69ABQ33437948-175F61FA-358C-4E12-AA17-07B1B9F2B37CQ33980682-58E48B32-50BF-4856-A809-0E26704BBAE9Q35092329-33311BCD-F596-44CE-90AF-845C0BEB2CB2Q35855571-DDCC90A4-EA5C-48B4-AC85-053B99F3DD25Q36737701-655A03C8-5144-4744-B0C9-E8828E9C1152Q37317571-081F4126-A740-4A9D-AAFA-0120988B7445Q37346201-6E034B07-F605-420B-BC57-8FEB477037E9Q37565233-8812AF63-0A38-4A6A-ADA9-34723BB6F2C5Q37821337-5ECCCD20-520E-4DC4-9FCB-F6F5904747DBQ37953826-0F50ADB4-FE30-4A1D-A2CF-7391E5389A6FQ37959304-31FA446D-B49F-41E7-96A4-CB16A7268180Q38148588-EEA6B2C0-CA3E-4F7F-B4A2-C33B6DDE8E41Q38223419-7DC0A3C1-DDFF-43C6-ACD3-2CB8CF99C652Q38318899-5748CD2E-2286-405B-9838-FC7656B8CB92Q38357137-FA45EE24-CB31-48F6-8239-6E8D9D84875BQ38400818-8D847B3F-8922-440D-8212-B3B5A17F588EQ38747135-057BF2AD-C60A-4F37-9F16-2B99FA82CA90Q40416435-DB0D64E4-81BC-457C-9A48-A1FD99588883Q41768675-8FFCEE11-C9A5-4153-8D09-A698B1AADAC9Q49557954-7BEB677D-D839-47F5-BBBD-B902FF75376DQ57570339-345CD093-50E3-4B72-8002-E78DDF3C6DF1Q58699767-0CE51B4C-4333-44C4-B542-5ACE7E49FE22
P2860
An epigenetic vaccine model active in the prevention and treatment of melanoma
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
An epigenetic vaccine model active in the prevention and treatment of melanoma
@ast
An epigenetic vaccine model active in the prevention and treatment of melanoma
@en
type
label
An epigenetic vaccine model active in the prevention and treatment of melanoma
@ast
An epigenetic vaccine model active in the prevention and treatment of melanoma
@en
prefLabel
An epigenetic vaccine model active in the prevention and treatment of melanoma
@ast
An epigenetic vaccine model active in the prevention and treatment of melanoma
@en
P2093
P2860
P356
P1476
An epigenetic vaccine model active in the prevention and treatment of melanoma
@en
P2093
A Nazmul H Khan
Thomas B Tomasi
William J Magner
P2860
P2888
P356
10.1186/1479-5876-5-64
P577
2007-12-10T00:00:00Z
P5875
P6179
1022189497